Mercachem-Syncom Group BV

The Mercachem-SyncomGroup has a proven track record of almost 30 years supporting leading pharma and biotechnology companies withinnovative and complexmedicinal chemistry programs. Starting as a chemistry service provider,the Grouphas transformed into an integrated drug discovery CRO offering innovative chemistry, medicinal chemistry, library synthesis, early process research servicesand cGMP manufacturing servicesto accelerate the drug discovery and development process in a flexible and cost-effective way. Furthermore, the Group has developedindependently novel chemical matter in a number of areas, including CDK8 and sumoylation inhibitors (Sumiq Therapeutics) which will befurther developed in milestone-based partnerships. The Mercachem-SyncomGroup is recognized asa world leader in chiral chemistry with a strong focus on chiral resolution technology. With close to250 chemists (> 50% PhD)working in state-of-the-art laboratory facilities, the Group serves many pharmaceutical and biotech companies throughout the worldandis renowned for its high-quality services and problem-solvingcapabilities.


Mercachem-Syncom Group BV

Kerkenbos 1013
6546 BB
Sonstige Tätigkeitsfelder